NCT05023798View on ClinicalTrials.gov

Study to Evaluate a Prototype Non-Invasive BG Measurement System

UnknownOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Interventions

DEVICE

ATD (device test)

Medical device test (no intervention)

Trial Locations (1)

SA2 8PP

JCRF, Swansea

Sponsors

Lead Sponsor

Afon Technology

All Listed Sponsors

lead

Afon Technology

INDUSTRY

NCT05023798 - Study to Evaluate a Prototype Non-Invasive BG Measurement System | Biotech Hunter | Biotech Hunter